Related Experiment Video
Updated: May 17, 2025

10:35
Simultaneous PET/MRI Imaging During Mouse Cerebral Hypoxia-ischemia
Published on: September 20, 2015
12.2K
18F-FDG Brain PET/MRI in Postischemic Hyperperfusion.
Faizullah Mashriqi1, James Kim, Ana M Franceschi
1Department of Radiology, Neuroradiology Division, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lenox Hill Hospital, New York, NY.
Clinical Nuclear Medicine
|April 3, 2025
Summary
This study details a stroke patient experiencing memory issues. Brain imaging revealed focal hypermetabolism in infarct areas, identified as luxury perfusion, not neurodegeneration.
Area of Science:
- Neurology
- Neuroimaging
- Stroke Medicine
Background:
- A 58-year-old male with a history of myocardial infarction and ventricular thrombus presented with recurrent stroke symptoms.
- Initial symptoms included left arm weakness, followed by dysarthria and right-sided weakness, indicating cerebrovascular events.
Purpose of the Study:
- To investigate the cause of impaired memory in a stroke patient that was not explained by ischemic areas.
- To differentiate between neurodegenerative disease and other causes of cognitive impairment using advanced neuroimaging.
Main Methods:
- Structural imaging (CT/MRI) was used to identify acute/subacute ischemic stroke locations in the right frontal and parietal lobes.
- 18F-FDG brain PET/MRI was performed to evaluate for neurodegenerative disease and assess metabolic activity in brain regions.
Main Results:
- Structural imaging confirmed ischemic strokes in the right frontal and parietal lobes.
- 18F-FDG brain PET/MRI ruled out neurodegenerative disease.
- Focal hypermetabolism was observed in the acute/subacute infarct areas, consistent with luxury perfusion (postischemic hyperperfusion).
Conclusions:
- The patient's memory impairment was attributed to luxury perfusion in the infarct areas, not a primary neurodegenerative process.
- 18F-FDG brain PET/MRI is a valuable tool for differentiating post-stroke hyperperfusion from neurodegeneration in cognitive impairment workups.
More Related Videos
Related Concept Videos
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
56
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
56

![PET Imaging of Neuroinflammation Using [11C]DPA-713 in a Mouse Model of Ischemic Stroke](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F57243.jpg&w=3840&q=50)